Uniting for One Mission

Meet the visionaries behind the world’s top global coalition united in the fight against cancer.

Chief Executive Officer
Alicia Zhou, PhD
Chief Development Officer
Rachael Brown, MA
Marketing Specialist
Maureen DeGregorio
Planned Giving Specialist
Bethany Disanno
Director of Communications
Dustin Etheridge
Executive Assistant
Jess Garcia
Chief Operating Officer
Scott Glenn, MA
Senior Manager of Research Programs
Ryan Godfrey
Chief Program Officer
Lynne A. Harmer
Manager of Community Fundraising
Cierra Howard
Development Officer
Rebecca Jensen, MA
Development Officer
Abbey Kolff
Director of Foundation and Corporate Relations
Marla S. Lawson
Director of Major Gifts
Deanne Marbach
Administrative Assistant
Ashley Moure
Associate Director of Program Management
Shasell Negron
Senior Manager of Social Media
Amelia Rosenthal
Assistant Director of Donation Processing
Devi Sharma
Office Manager
Olivia Smith
Director of Scientific Affairs
Samik Upadhaya, PhD
Senior Director of Marketing
Wendy Weise
Director of Development Operations
Jacqueline Zimny

James P. Allison, PhD
The University of Texas MD Anderson Cancer Center
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Glenn Dranoff, MD
Dana-Farber Cancer Institute
Elizabeth M. Jaffee, MD
Johns Hopkins University School of Medicine
Carl F. Nathan, MD
Weill Cornell Medicine
Kunle Odunsi, MD, PhD
The University of Chicago
Ellen Puré, PhD
University of Pennsylvania School of Veterinary Medicine
Robert D. Schreiber, PhD
Washington University School of Medicine
E. John Wherry, PhD
University of Pennsylvania School of Medicine
Jedd D. Wolchok, MD, PhD
Weill Cornell Medicine
Frederick W. Alt, PhD
Boston Children’s Hospital & Harvard Medical School
Richard Axel, MD
Columbia University
Harvey Cantor, MD
Dana-Farber Cancer Institute & Harvard Medical School
Jonathan Cebon, PhD, FRACP
Olivia Newton-John Cancer Research Institute
Zhijian Chen, PhD
University of Texas Southwestern Medical Center
Max D. Cooper, MD
Emory University
Lisa M. Coussens, PhD
Oregon Health and Science University
Peter Cresswell, PhD
Yale University
Jason G. Cyster, PhD
University of California, San Francisco
Mark M. Davis, PhD
Stanford University
Charles G. Drake, MD, PhD
NewYork-Presbyterian / Columbia University Medical Center and Johnson & Johnson Innovative Medicine
Michael L. Dustin, PhD
University of Oxford
Kate A. Fitzgerald, PhD, MRIA
University of Massachusetts Medical School
Richard A. Flavell, PhD, FRS
Yale University
Thomas Gajewski, MD, PhD
The University of Chicago
Laurie H. Glimcher, MD
Dana-Farber Cancer Institute
Philip D. Greenberg, MD
Fred Hutchinson Cancer Research Center & University of Washington
Nir Hacohen, PhD
Broad Institute of MIT and Harvard
James R. Heath, PhD
Institute for Systems Biology
F. Stephen Hodi, MD
Dana-Farber Cancer Institute
Axel Hoos, MD, PhD
Scorpion Therapeutics
Patrick Hwu, MD
Moffitt Cancer Center
Darrell J. Irvine, PhD
Massachusetts Institute of Technology
Dirk Jaeger, MD
National Center for Tumor Diseases Heidelberg
Carl H. June, MD
University of Pennsylvania School of Medicine
Susan M. Kaech, PhD
Salk Institute for Biological Studies
Michael Kalos, PhD
Next Pillar Consulting, LLC
Michael Karin, PhD
University of California, San Diego
John M. Kirkwood, MD
University of Pittsburgh School of Medicine
Alexander Knuth, MD
Hamad Medical Corporation
Lewis L. Lanier, PhD
University of California, San Francisco
Christina S. Leslie, PhD
Weill Cornell Medicine
Hyam I. Levitsky, MD
Century Therapeutics
Ming O. Li, PhD
Weill Cornell Medicine
Dan R. Littman, MD, PhD
New York University Medical Center
Nils Lonberg, PhD
Canaan Partners
J. Christopher Love, PhD
Massachusetts Institute of Technology
Tak W. Mak, PhD, DSc, FRSC
University Health Network
Philippa C. Marrack, PhD
National Jewish Health & University of Colorado
Cornelis J.M. Melief, MD, PhD
Leiden University Medical Center
Ira Mellman, PhD
Genentech, Inc.
Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai
Malcolm A.S. Moore, DPhil
Memorial Sloan Kettering Cancer Center
Lee Nadler, MD
Harvard Medical School & Dana-Farber Cancer Institute
Drew M. Pardoll, MD, PhD
Johns Hopkins University School of Medicine
Klaus Rajewsky, MD
Max Delbrueck Center for Molecular Medicine
Gwendalyn J. Randolph, PhD
Washington University in St. Louis
Anjana Rao, PhD
La Jolla Institute for Immunology
Antoni Ribas, MD, PhD
University of California, Los Angeles Comprehensive Cancer Center
Stanley R. Riddell, MD
Fred Hutchinson Cancer Research Center & University of Washington
Alexander Rudensky, PhD
Memorial Sloan Kettering Cancer Center
Bijan Safai, MD, DSc
New York Medical College
Shimon Sakaguchi, MD, PhD
Osaka University
Lawrence E. Samelson, MD
National Cancer Institute, NIH
Hans Schreiber, MD, DMSc, PhD
The University of Chicago
Ton N. Schumacher, PhD
The Netherlands Cancer Institute & Leiden University Medical Center
Padmanee Sharma, MD, PhD
The University of Texas MD Anderson Cancer Center
Craig L. Slingluff Jr., MD
University of Virginia Health System
Pramod K. Srivastava, MD, PhD
University of Connecticut School of Medicine
Susumu Tonegawa, PhD
Massachusetts Institute of Technology
Giorgio Trinchieri, MD
National Cancer Institute, NIH
Marcel van den Brink, MD, PhD
City of Hope Los Angeles National Medical Center
Ulrich H. von Andrian, MD, PhD
Harvard Medical School
Robert H. Vonderheide, MD, DPhil
University of Pennsylvania
Jennifer Wargo, MD
The University of Texas MD Anderson Cancer Center
Hao Wu, PhD
Boston Children's Hospital & Harvard Medical School
Kai W. Wucherpfennig, MD, PhD
Dana-Farber Cancer Institute
Cassian Yee, MD
The University of Texas MD Anderson Cancer Center
Rolf M. Zinkernagel, MD, PhD
University of Zurich